Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Single droplet displacement infrared action spectroscopy.
Journal: Nature communications
Published: September 22, 2025
A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 18, 2019
Exploratory Analysis of Single-Gene Predictive Biomarkers in HERA DASL Cohort Reveals That C8A mRNA Expression Is Prognostic of Outcome and Predictive of Benefit of Trastuzumab.
Journal: JCO precision oncology
Published: November 01, 2018
Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 24, 2018
High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers.
Journal: JCO precision oncology
Published: October 13, 2017
Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial.
Journal: JAMA oncology
Published: April 22, 2016
ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.
Journal: Breast cancer research and treatment
Published: November 04, 2015
CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
Journal: Breast cancer research and treatment
Published: April 07, 2015
Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs.
Journal: Meta gene
Published: February 18, 2015
Last Updated: 09/26/2026